Light smoking at base-line predicts a higher mortality risk to women than to men; evidence from a cohort with long follow-up by Hurley, Margaret A
Hurley BMC Public Health 2014, 14:95
http://www.biomedcentral.com/1471-2458/14/95RESEARCH ARTICLE Open AccessLight smoking at base-line predicts a higher
mortality risk to women than to men; evidence
from a cohort with long follow-up
Margaret A HurleyAbstract
Background: There is conflicting evidence as to whether smoking is more harmful to women than to men. The UK
Cotton Workers’ Cohort was recruited in the 1960s and contained a high proportion of men and women smokers
who were well matched in terms of age, job and length of time in job. The cohort has been followed up for
42 years.
Methods: Mortality in the cohort was analysed using an individual relative survival method and Cox regression.
Whether smoking, ascertained at baseline in the 1960s, was more hazardous to women than to men was examined
by estimating the relative risk ratio women to men, smokers to never smoked, for light (1–14), medium (15–24),
heavy (25+ cigarettes per day) and former smoking.
Results: For all-cause mortality relative risk ratios were 1.35 for light smoking at baseline (95% CI 1.07-1.70), 1.15 for
medium smoking (95% CI 0.89-1.49) and 1.00 for heavy smoking (95% CI 0.63-1.61). Relative risk ratios for light
smoking at baseline for circulatory system disease was 1.42 (95% CI 1.01 to 1.98) and for respiratory disease was
1.89 (95% CI 0.99 to 3.63). Heights of participants provided no explanation for the gender difference.
Conclusions: Light smoking at baseline was shown to be significantly more hazardous to women than to men but
the effect decreased as consumption increased indicating a dose response relationship. Heavy smoking was equally
hazardous to both genders. This result may help explain the conflicting evidence seen elsewhere. However gender
differences in smoking cessation may provide an alternative explanation.Background
A recent cohort study of over one million women born
around 1940 in the UK showed that two thirds of deaths
of women smokers in their 50s, 60s and 70s were due to
smoking related disease and that women smokers lost at
least 10 years of life [1]. For the US, it has been esti-
mated that there were 291,000 smoking attributable
deaths among men and 229,000 deaths among women
in the years 2002 to 2006 [2]. Hence, there is universal
agreement that smoking tobacco is harmful to all. How-
ever, for over a decade there has been a continuing crit-
ical debate as to whether the same level of smoking
exposure is more harmful to women than to men [3-11].
A number of studies have shown that the hazard of lung
cancer, and similarly the hazard of chronic obstructiveCorrespondence: MAHurley@uclan.ac.uk
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reproduction in any medium, provided the orpulmonary disease, are about equal for men and for
women whereas other studies have demonstrated that
women smokers are at greater risk of smoking-related dis-
ease, such as coronary heart disease, compared to men for
the same amount of smoking [12-14]. A recent compari-
son of two different Australian cohorts one of men and
one of women, concluded that men and women with simi-
lar patterns of smoking experience had similar mortality
from smoking related disease [15]. Yet, the accompanying
editorial concluded that the total evidence to date from
both epidemiology and biology suggested that there might
well be differences in the health consequences of smoking
for men and women but that study limitations obscured
the evidence for a gender difference in smoking-related
mortality [16]. Previous studies have not used an individ-
ual relative survival approach and this certainly has been a
limitation of published analyses [17]. An individual relative
survival analysis makes the very best use of the availablehis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Table 1 Participants in the cohort at recruitment and
follow-up to 31st December 2007
Men
N = 1548
Women
N = 1911
Demographics at recruitment:
Age at 1 Jan 1966 (yrs): Mean (SD) 39.2 (15.6) 43.1 (12.3)
Age at 1st examination (yrs): Mean (SD) 41.5 (15.6) 45.6 (12.2)
Time worked in cotton industry (yrs): 1 to 3 193 (13%) 73 (4%)
4 to 10 286 (19%) 226 (12%)
11 to 20 322 (21%) 435 (23%)
21 to 40 542 (35%) 846 (44%)
More than 40 205 (13%) 331 (17%)
Smoking status: Never smoked 333 (22%) 856 (45%)
Light smoker (1–14 cigarettes per day) 589 (38%) 615 (32%)
Medium smoker (15–24 cigarettes per day) 445 (29%) 337 (18%)
Heavy smoker (25+ cigarettes per day) 91 (6%) 54 (3%)
Former smoker 90 (6%) 49 (3%)
Follow-up:
Number of workers 1548 1911
Embarked before age 90 44 44
Embarked after age 90 0 2
Censored at age 90 then died later 40 101
Censored at age 90 and still alive 6 39
Died before age 90 900 1118
Alive and younger than age 90 558 607
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ences that aggregated data may fail to detect. Individual
relative survival provides a powerful statistical analysis.
Also cohorts are rare which contain both men and women
together and which have been followed up for many years.
This paper uses an individual relative survival approach to
the analysis of a cohort of cotton mill workers which con-
tained 42 years of mortality data and looks at the female
to male relative risk of smoking compared to never having
smoked.
Methods
Participants
In 1966 Her Majesty’s Factory Inspectorate (now part of
the UK Health and Safety Executive) initiated a study of
workers in cotton manufacturing mainly in Lancashire,
England. From 1966 to 1970, around 3500 workers from
52 mills were medically examined to determine their
current respiratory health. This included a physical lung
function test to determine forced expiratory volume in
one second (FEV1) and forced vital capacity (FVC). A
health questionnaire ascertained smoking grade; never
smoker, light smoker (1–14), medium smoker (15–24),
heavy smoker (≥ 25 cigarettes per day) and former
smoker together with presence of cough and phlegm at
least 3 days per week for at least 3 months of the year
and whether the worker had the lung disease Byssinosis.
Height was also recorded. Demographics of the cohort
are given in Table 1. The workers were later traced and
flagged for vital status at the National Health Service
(NHS) Central Register for England and Wales (now the
NHS Information Centre) with the aim of exploring the
effect of current respiratory health on future longevity
and cause of death. By 1972 most mills had closed [18].
Analyses of the mortality to 1984 and to 2007 have been
reported [19,20]. By the end of follow-up at 31st Decem-
ber 2007, 2018 workers had died before age 90 years
(Table 1). The focus of earlier studies was to ascertain
whether exposure to cotton dust was protective for lung
cancer [19,20]. The cotton industry in Lancashire was
notable in that it provided full-time employment for very
many women. Therefore, this cohort contained both
men and women working mostly full-time, doing identi-
cal jobs in the work place and in the same work place
settings and with a high proportion of women smokers
across the spectrum of consumption (Figure 1). Men
and women’s ages spanned the entire age range from less
than 20 years to more than 70 years and men and
women both had a similar employment history in terms
of years in the industry (Figure 1). Hence these data on
men and women are well matched and provide a seren-
dipitous opportunity for making gender comparisons of
the influence of smoking on the subsequent mortality of
the men and women workers.Statistical methods
An individual relative survival approach was used be-
cause age at entry to the cohort in 1966 to 1970 varied
widely, from less than 20 to over 70 years of age [21-23].
It was also required because residual life expectancy had
rapidly increased in England between 1966 and 2007
[24]. Relative survival is becoming recognised as the
most appropriate approach for many cohort studies [25].
Individual relative survival was calculated using mortal-
ity at mid-year population estimates for England and
Wales for 1966 to 2007 for all-cause mortality and for
six specific causes of death, namely lung cancer, all can-
cers except lung, circulatory systems disease, ischemic
heart disease, cerebrovascular disease, respiratory system
disease and bronchitis, emphysema and other COPD
[26]. The different ICD codes for these disease groupings
over the time interval 1966 to 2007 were given previously
[20]. Using these reference population estimates, the ob-
served survival times were transformed to the measure of
individual relative survival [21]. In a similar way to Poisson
regression using expected values, the computation of the
measures of individual relative survival adjusts for the ef-
fects of age and chronological time at entry, and also in-
creasing age and advancing chronological time during
Figure 1 Worker demographics. Histograms that show the demographics of the men and women cotton workers.
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The individual relative survival times were then modelled
using Cox’s regression adjusted for the confounding vari-
ables; byssinosis, cough and phlegm, time worked in the
cotton industry, FEV1% predicted and FVC, scaled appro-
priately to aid interpretation [21-23]. The risk factors of
interest were included, namely smoking grade at baseline,
gender and the interaction between smoking grade and
gender. The interaction was parameterised as three or four
female to male, smoker to non-smoker relative risk ratios
(RRR). These were for light, medium, heavy and former
smoking in the case of four RRRs (all-cause mortality) or
light, medium/heavy and former smoking in the case of
three RRRs (cause specific and all-cause mortality). The
proportional hazards assumption was tested for the Cox’s
regression model using the correlation coefficient (ρ) be-
tween the scaled Schoenfeld residuals and the transformed
survival times. Further, for all-cause mortality, the individ-
ual relative survival measure (Y) was transformed to Z =
−log(1-Y) where Z is an alternative measure of individual
relative survival. The alternative measure yields identical
model coefficients when analysed using Cox’s regression
model, which is semi-parametric, but has the property that
it can be modelled fully parametrically using, for example,
the Weibull model. Therefore this latter measure provides
mortality predictions for different scenarios. The program-
ming was carried out in the R programming language
[28].
Dependent and independent variables
In detail, the dependent variable in the Cox and Weibull
regressions was the transformed survival time, the trans-
formation being that which removed the effects of age and
chronological time using the gender specific England andWales mortality rates from 1966 to 2007 [26]. For each
participant the measure of individual relative survival was
the transformed survival time.
The independent variables in the regression were those
ascertained at first medical examination, namely
1. Smoking grade category; never smoker, light smoker
(1–14), medium smoker (15–24), heavy smoker (≥
25 cigarettes per day) and former smoker
2. Gender; male (coded 0) or female (coded 1)
3. Female light smoker; no (coded 0) or yes (coded 1)
4. Female medium smoker; no (coded 0) or yes (coded 1)
5. Female heavy smoker; no (coded 0) or yes (coded 1)
6. Female former smoker; no (coded 0) or yes (coded 1)Indicator variables 3, 4, 5 and 6 provided estimates
of the four RRRs for light, medium, heavy and
former smoking and comprise the four degrees of
freedom of the gender smoking grade interaction.
7. Presence of the lung condition Byssinosis; no (coded 0)
or yes (coded 1)
8. Presence of cough and phlegm; no (coded 0) or yes
(coded 1)
9. Lung function covariate expressed as (100 - FEV1%
predicted)/10. If lung function was 100% of that pre-
dicted for a person of that same age, height and gen-
der, then the covariate takes the value zero. If lung
function was 90% of that predicted for a person of
that same age, height and gender, then the covariate
takes the value 1. The hazard ratio in the survival
model can then be interpreted as the increased mor-
tality hazard for a 10% reduction in FEV1% predicted
at time of first medical examination.
10. Lung function covariate expressed as (100(FEV1/
FVC)-100)/10. If the FEV1 to FVC ratio is 1 then
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FVC (reduced lung function) then the covariate
takes the value 1 and the hazard ratio in the
survival model can be interpreted as the increased
mortality hazard for a 10% reduction in the ratio.
11. Height at first medical examination.
Ethical approval
Ethical approval for these studies was obtained from the
University of Central Lancashire’s Faculty of Health Re-
search Ethics Committee which accepted that the study
had been granted exemption by the Department of
Health’s National Information Governance Board from
the need to obtain informed consent from individuals
retrospectively to participate in the mortality study. In
addition the Medical Research Information service at
the NHS Information Centre granted permission for the
study to receive vital status data.
Results
The correlation coefficient (ρ) between the scaled Schoenfeld
residuals and the transformed survival times are shown in
Table 2 and all correlations were less than 0.05 in magni-
tude indicating that the proportional hazards assumption
was acceptable. The anticipated effect of smoking on all-
cause mortality was evident (Table 2) with hazard ratios
(HR) in the Cox regression of 1.21 (95% CI 1.00-1.46)
for light smoking, 1.68 (95% CI 1.34-2.00) for mediumTable 2 Hazard ratios (HR) for all-cause mortality to 31st Dece
Weibull model*
HR 95% CI P H
Never smoked 1.00 1
Light smoker 1.21 1.00 1.46 .051 1
Medium smoker 1.68 1.38 2.05 <.001 1
Heavy smoker 2.01 1.51 2.68 <.001 1
Former smoker 0.89 0.66 1.21 .465 0
Male 1.00 1
Female 1.10 0.92 1.32 .304 1
Light smoker RRR 1.35 1.07 1.70 .012 1
Medium smoker RRR 1.13 0.87 1.46 .361 1
Heavy smoker RRR 0.98 0.61 1.58 .942 1
Former smoker RRR 1.11 0.68 1.80 .681 1
Byssinosis absent 1.00 1
Byssinosis present 1.04 0.93 1.16 .484 1
Cough and phlegm absent 1.00 1
Cough and phlegm present 1.07 0.97 1.18 .158 1
One decade in the cotton industry 0.91 0.88 0.94 <.001 0
FEV1: 10% decrease below normal 1.07 1.04 1.10 <.001 1
FEV1 to FVC ratio: decrease of 10% 1.01 0.95 1.07 .763 1
*LogL = −1813.7, Shape 1.08 (95% CI 1.04 to 1.12).smoking and 1.99 (1.49-2.65) for heavy smoking relative to
never having smoked. The female to male RRRs demon-
strated a dose response relationship; the RRR was signifi-
cantly elevated above unity for light smoking (1.35; 95%
CI 1.07-1.70) was lower but not significant for medium
smoking (1.15; 95% CI 0.89-1.49) and lower again and in-
significant for heavy smoking (1.00; 95% CI 0.63-1.61).
The parametric Weibull model was found to be an ac-
ceptable fit to the alternative measure of individual rela-
tive survival with highest likelihood amongst a range of
tested alternative models. The HRs and RRRs were vir-
tually identical to those obtained by the Cox model im-
plying robustness to choice of model. It would seem
therefore, for this cohort at least, that light smoking at
baseline was relatively more harmful to women than to
men in terms of all-cause mortality. The effect reduced
as smoking level increased and there was no gender dif-
ference for heavy smokers.
It has been suggested that any gender difference in risk
can be explained by the difference in the physical size of
women compared to men [29]. The same consumption
in a smaller pair of lungs might induce greater damage.
Hence the logarithm of height was added to the models,
assuming an allometric relationship between height and
lung volume. This variable was not even close to signifi-
cant and the RRR values were unchanged. The gender
difference seen in this cohort could, therefore, not be as-
cribed to size difference.mber 2007 from the regression models
Cox model Proportional hazards assumption
R 95% CI P ρ P
.00
.21 1.00 1.46 .055 −0.012 .60
.64 1.34 2.00 <.001 0.000 .99
.99 1.49 2.65 <.001 −0.042 .06
.89 0.66 1.22 .475 −0.012 .60
.00
.07 0.89 1.29 .471 −0.020 .36
.35 1.07 1.70 .012 −0.008 .71
.15 0.89 1.49 .290 −0.029 .19
.00 0.63 1.61 .990 −0.021 .35
.10 0.68 1.78 .705 −0.026 25
.00
.04 0.93 1.15 .535 −0.010 .67
.00
.07 0.97 1.18 .155 0.031 .17
.91 0.88 0.95 <.001 0.047 .04
.07 1.04 1.10 <.001 0.014 .54
.01 0.96 1.07 .726 0.001 .97
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lung function variables were removed from the model.
As a consequence light smoking became more signifi-
cant (P = 0.01 in the Cox model) but the RRRs remained
unchanged. When only the variables gender, smoking
grade and the RRRs remained in the model, the RRR for
light smoking increased to 1.39 (95% CI 1.10 to 1.75) in
the Cox model (P = 0.005). Therefore, the result regard-
ing the greater mortality risk to women of light smoking
at baseline in this cohort was robust to the inclusion of
confounding variables.
The cause specific female to male RRRs were esti-
mated using the same model as for all-cause mortality,
except that three RRRs were estimated since numbers of
deaths were smaller than for all-cause mortality. The es-
timates are shown in Table 3. For light smoking the
RRRs are elevated above unity for all specific causes, sig-
nificantly so for circulatory system diseases (P = 0.042)
and close to 5% significance for respiratory system dis-
ease (P = 0.054) and bronchitis, emphysema and other
COPD (P = 0.052). The estimated RRR for the latter was
3.4 (95% CI 1.0 to 11.9) indicating that, for women, mor-
tality risk may be of the order of three times that for
men. For medium/heavy smoking there was no evidence
of a greater risk to women compared to men.
Table 4 shows the predicted 5%, 50% (median) and 95%
percentile for the residual lifetime for a cohort participant
aged 25, 45 and 65 years of age at 1st January 1965. These
values were obtained from the Weibull model which in-
cluded gender, smoking grade and four RRRs. For an indi-
vidual of 45 years of age, light smoking reduced a man’s
median residual lifetime by 2.6 years compared to never
having smoked, whereas for a woman the reduction was
5.9 years (3.3 years difference in median years of life lost).
For medium smoking the analogous values are 6.4 for
men and 7.6 for women (1.2 years difference in reduction)
and for heavy smoking 8.2 years for men and 7.8 years for
women (−0.4 years difference in reduction). This providesTable 3 Relative risk ratios (RRR) estimated by Cox’s regressio
Light smokers
RRR 95% CI P
All causes 1.35 1.07 1.70 0.012
Lung cancer* 1.40 0.22 9.12 0.724
All cancers excluding lung 1.09 0.65 1.85 0.735
Circulatory systems disease 1.42 1.01 1.98 0.042
Ischemic heart disease 1.33 0.86 2.07 0.203
Cerebrovascular disease 1.45 0.74 2.85 0.278
Respiratory system disease 1.89 0.99 3.63 0.054
Bronchitis, emphysema and other COPD 3.44 0.99 11.9 0.052
*No women former smokers died of lung cancer.another way of understanding the greater risk to women
of light smoking compared to men for this cohort.
The predicted mortality percentages for cohort partici-
pants aged 45 at 1st January 1965 for men and women
who had never smoked, who were light, medium or
heavy smokers, are shown in Figure 2. The survival ad-
vantage of women over men is clear for those who have
never smoked, since the gap is wide. For light smokers
the gender gap is considerably narrowed but as smoking
grade increases to heavy smoking, the full gender gap
becomes re-established. The interaction between smok-
ing grade and gender is clearly visible.
Discussion
This study shows clear evidence that light smoking mea-
sured at baseline predicted a higher mortality risk to
women than to men for participants in the cotton
workers’ cohort and that an elevated risk was evident for
diseases of the circulatory system and the respiratory sys-
tem, especially bronchitis, emphysema and other COPD.
The results of these analyses are in contrast to those ob-
tained from the analysis of two Australian cohorts [15].
The Australian cohorts were large; 12,154 men and 11,707
women with 3549 and 2665 deaths respectively during the
10-year follow-up period. However the Australian cohorts
contained only 1317 and 912 current smokers of whom
809 men and 434 women were light smokers. Age at entry
to the Australian cohort was 65 for men and 70 for
women and so these cohorts contained only those who
were elders. The cotton workers cohort was much smaller
with 1548 men and 1911 women but 900 and 1118 deaths
before age 90. Those recorded as current smokers at base-
line were 1125 men and 1006 women of whom 589 and
615 respectively were light smokers. Thus the cotton
workers’ cohort had more women smokers and more
women light smokers than the Australian cohort despite
the latter’s much larger size. The follow-up for the cotton
workers’ cohort was for 42 years and age at entry coveredn for different causes of death
Medium/heavy smokers Former smokers
RRR 95% CI P RRR 95% CI P
1.12 0.87 1.43 0.381 1.10 0.67 1.78 0.705
2.00 0.31 12.6 0.466
1.07 0.60 1.89 0.825 0.77 0.22 2.68 0.685
1.05 0.73 1.51 0.802 1.03 0.53 2.02 0.924
0.99 0.62 1.59 0.971 1.16 0.46 2.93 0.749
1.09 0.51 2.30 0.829 1.01 0.31 3.33 0.983
1.58 0.81 3.07 0.182 2.09 0.68 6.41 0.197
2.71 0.78 9.39 0.116 6.68 1.04 42.9 0.045
Table 4 Residual lifetime percentiles conditional on age at 1st January 1965 and reported smoking status
Age at death (years)
Never smoked Light smoker Medium smoker Heavy smoker
Predicted survival percentile1 Men Women Men Women Men Women Men Women
Age at 1st Jan 1965
25 years 5% 54.92 59.50 52.33 53.33 49.08 51.67 47.08 51.42
50% 82.83 85.83 80.75 81.33 77.17 80.17 75.50 80.00
95% 100.50 103.92 96.33 94.08 91.25 92.08 89.17 91.83
45 years 5% 55.25 58.92 54.00 55.00 52.00 53.92 51.17 90.50
50% 78.50 84.33 75.92 78.42 72.08 76.75 70.33 76.50
95% 98.00 102.58 93.75 92.75 88.67 90.83 86.58 53.75
65 years 5% 66.75 68.42 66.62 67.00 66.00 66.75 65.83 66.75
50% 78.58 83.33 76.75 79.08 74.58 77.75 73.33 77.58
95% 94.00 100.08 90.58 91.25 86.58 89.50 85.17 89.25
1assumes force of mortality remains constant at 2007 values from 2008 onwards.
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Estimates of hazard ratios from the US 1997–2004 National
Health Interview Survey and its follow-up showed higher
hazard ratios for women compared to men for all four
levels of smoking grade in age groups 35 to 44, 45–54 and
55 to 64 years. For the age groups 65 to 74 and 75 to 84
hazard ratios were similar [2]. These results might suggest
that a cohort of men and women recruited after age 65
would not give estimates applicable across the full age
range. Therefore it is possible that the results from the cot-
ton workers’ cohort may have wider validity than that for
the Australian cohorts.Figure 2 Mortality curves. Predicted mortality curves for men and wome
were light smokers (1 to 14 cigarettes per day), medium smokers (15 to 24
Solid line shows mortality for men and broken line for women.A systematic review and meta-analysis of the risk of cor-
onary heart disease estimated the women-to-men relative
risk ratio of smoking compared to not smoking at 1.25
(95% CI 1.12 to 1.39) [14]. The relative risk ratio obtained
from the cotton workers’ cohort study for mortality from
ischematic heart disease was 1.33 (95% CI 0.86 to 2.07) for
light smoking compared to not smoking. Clearly these
two relative risk ratios are not quite comparable but they
do demonstrate that the magnitudes of estimates obtained
in this study were plausible. It has also been estimated pre-
viously that acute myocardial infarction occurs earlier in
women smokers than in men smokers and twice as manyn who attained age 45 at 1st January 1965 and who never smoked,
cigarettes per day) or heavy smokers (25 or more cigarettes per day).
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men smokers [30]. These findings accord with the current
study for light smokers since the estimated median re-
sidual lifetime of a 45 year old woman light smoker was
reduced by 5.9 years compared to 2.6 years for her male
counterpart in the cohort. A matched case control study
using the UK medical research database known as The
Health Improvement Network (THIN) demonstrated that
smoking carried a significantly higher risk of lung cancer
in women compared to men [31]. The estimated relative
risk ratio was 1.5 for women ever smoking 20 or more cig-
arettes per day and this ratio accords with the current
study where the estimated ratio was 1.4 for women smok-
ing 1 to 14 cigarettes per day and 2.0 for women smoking
15 or more cigarettes per day at baseline. The THIN study
similarly found that height provided no explanation for
the gender difference. A systematic review and meta-
analysis of 81 cohorts looked at smoking as a risk factor
for stroke in women compared to men and concluded that
there was a similar risk overall [32]. This concurs with the
current study which found no evidence for a gender differ-
ence in mortality from cerebrovascular disease.
The present study showed the greatest median number
of years of life lost was 8 years for women born around
1920 who were heavy smokers. This estimate is less than
that for the million women’s study for which a 10 year
loss of life was estimated [1]. The two estimates are not
wholly comparable because of the difference in age at re-
cruitment and the stage at which smoking status was re-
corded but are sufficiently similar to suggest the validity
of the findings of this study.
The cotton workers’ study was started in the mid-1960s
and consequently benefits from very long follow-up. How-
ever, key confounding variables such as lipid levels, dia-
betes, weight, body mass index and blood pressure were
not included because their role in longevity was not
understood at the time the study was designed and this is
a limitation of the analysis. Also, smoking consumption in
the cotton workers’ study was self-reported, similar to
many studies of this type. However for the cotton workers’
cohort self-reporting was in 1966 to 1970, a period of time
when smoking in the UK had wide social acceptance. Par-
ticipants were recording current behaviour and hence bias
in reporting would be small. However, no information was
collected regarding smoking consumption for the partici-
pants during the many years of follow-up and only subse-
quent embarkation or cause of death was recorded. This
presents a limitation to the interpretation of the study
findings. If, for example, women participants had found
smoking cessation more difficult to achieve than their
male counterparts, this could provide an alternative ex-
planation for their greater susceptibility to the detrimental
effects of smoking due to greater total lifetime exposure.
Whether women in the cohort would have found smokingcessation more difficult than men is difficult to assess. A
comparison of data from three general population surveys
conducted in 2006 to 2007 in the USA, Canada and Britain
concluded that, across all age groups, there was little differ-
ence in cessation between the sexes [33]. However, a com-
parison of two case–control studies for lung cancer, one
completed in 1950 and one completed in 1990 showed
that, amongst the controls, prevalence of smoking had
fallen from 79.2% to 21.5% for men and from 38.0% to
20.1% for women over those four decades [34]. The study
concluded that women and older men were more likely to
have been persistent cigarette smokers throughout their
lives compared to men in early to middle age. In conclu-
sion therefore, there was a statistically significant gender
difference in relative long term survival comparing light
smokers at baseline. The observed gender difference could
be due to differences in physiology between men and
women. However, an alternative explanation might be gen-
der based differences in smoking cessation and this possi-
bility cannot be discounted.
The finding, of a dose response relationship in which
light smoking at baseline showed a greater gender differ-
ential compared to medium and heaving smoking, was a
surprising outcome. The data available in this study can-
not provide an explanation of this outcome but it does
suggest that future studies should not compare smokers
with non-smokers but that gender comparisons should
be stratified by level of tobacco consumption.
Conclusions
The results of this study demonstrate a dose response
relationship in the relative risk ratios of women to men
smoker to never smoked. The finding of a dose response
relationship and a failure to take a relative survival ap-
proach provide an explanation for the lack of consensus
in the literature about the gender difference in smoking
risk. It has been noted that women smokers in the USA
at least are more likely than men smokers to be light
daily smokers and so the greater risk to women of light
smoking will impact disproportionately on study out-
comes [35].
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